| 摘要 |
BTL.012 is a novel human protein useful for regulating or modulating angiogenesis. BTL.012, or variants thereof, may be employed as therapeutics in diseases such as cancer, wound healing, diabetic retinopathies, macular degeneration, and cardiovascular diseases, and other diseases or clinical conditions where angiogenesis is relevant to the causation or treatment of the disease.
|
| 申请人 |
BAYER CORPORATION;CHEN, JIANMIN;CHEN, DADONG;ZOLOTOREV, ALYA;DAVIES, CHRISTOPHER, J.;WETZEL, GAYLE, DELMONTE;DUBOIS-STRINGFELLOW, NATHALIE, A. |
发明人 |
CHEN, JIANMIN;CHEN, DADONG;ZOLOTOREV, ALYA;DAVIES, CHRISTOPHER, J.;WETZEL, GAYLE, DELMONTE;DUBOIS-STRINGFELLOW, NATHALIE, A. |
